Mr. Simes has been helpful in the wealth destruction part of my portfolio. The RestorGenex-DFFN axis has been the opposite of "increasing stockholder value" (quoting from CYDY PR). Nothing close to product approval or impending approval. Massive dilution/reverse split. But hey, that's the biotech start up world, right? A guy like Stevo can make a career of raising funds, promoting the beauty of a lip-sticked pig, and then moving on. RestorGenex was one of those so-many-shots-on-goal thingies. After the DFFN union, many projects were put on the shelf <LL vs Long Covid?>. One molecule massively increased oxygen delivery to tissues: implications for treatment of stroke, limb ischemia, cancers like Glioblastoma/brain/pancreas which can thrive in a low-oxygen environment.

This message board has had a strong bent towards helping people (patients). I certainly understand opinions formed based on years of waiting and a subsequent desire to be acquired and move on.

Good to meet you, Steve. Oh, you're in biotech? No wonder you can live in this neighborhood. What was your drug/device? Wait, what, zilch? Steve, please step away from my leronlimab.

I hold DFFN; wating/planning to sell for the partial offset against CYDY gains. [Offset is likely not the proper term.]

I have no knowledge about Mr. Dunlap. If Cyrus thinks these guys can help us, I'll go with the flow.